NanoTYPE™ HLA-11 Plus
Experience the power of true full-gene HLA genotyping with NanoTYPETM HLA-11 Plus— covering all 11 classical loci from 5’UTR to 3’UTR. Seamlessly integrated with Oxford Nanopore TechnologiesTM (ONT) long-read platforms, it delivers uninterrupted phasing, fast library prep, and unambiguous results—even in highly polymorphic regions.
The Details
NanoTYPETM HLA-11 Plus: Full Coverage. Future Ready.
Our assay design spans from the 5’UTR to the 3’UTR, enabling full-gene phasing and precise, unambiguous allele assignment across the entire gene.
Simple, Fast and Accurate. Now with Full Gene Coverage.
Product Benefits
Software Analysis
Example of full phasing of DPB1*01:01:01:01 / 04:01:01:01
A dedicated visual panel showcases the Signal-to-Noise ratio and highlights allelic balance between chromosomes—delivering clarity and confidence in every result.
Full set of quality control metrics available for every HLA locus
NanoTYPER provides QC metrics per locus, including key exon minimum coverage, allele imbalance, spot noise ratio, and N50 read length. These metrics ensure transparent assessment of sequencing quality and genotyping reliability across all 11 HLA genes.
Product availability varies by region; please check with your local Werfen representative for regulatory status in your area. The product is CE-IVDR within the European Union.
Bibliothèque de ressources
PACKAGE INSERTS (PI/ IFU), SAFETY DATA SHEETS (SDS), CERTIFICATES of ANALYSIS, LOT SPECIFIC FILES, and more can be accessed on our customer center.
Nos Certifications
Autres Produits
Événements,
Webinaires et Ateliers A Venir
Découvrez Nos Actualités
Actualités et blogs
Werfen Introduces NanoTYPE™ HLA-11 Plus CE— First CE-IVD HLA Typing Kit with Full-Gene Coverage for All 11 Classical HLA Genes
Werfen, a global leader in specialized diagnostics, announced the availability of NanoTYPETM HLA-11 Plus as CE-IVD (according to IVD-R), a next-generation HLA typing assay offering true full-gene coverage — from 5′UTR to 3′UTR — across all 11 classical HLA genes....
Actualités et blogs
Werfen acquiert Omixon
Werfen a finalisé l'acquisition d'Omixon, une société privée basée à Budapest, en Hongrie, qui se...
Actualités et blogs
Logiciel de typage HLA MIA FORA TM NGS EXPRESS : vous avez parlé, nous vous avons écouté !
Présentation du logiciel de typage HLA MIA FORA NGS EXPRESS, la prochaine étape d'Immucor pour...
Actualités et blogs
Bientôt disponible : Détectez les DP avec LIFECODES ® LifeScreen Deluxe !
Immucor est en train d'améliorer notre LIFECODES ® LifeScreen Deluxe (LMX) pour ajouter des billes...
Actualités et blogs
TEMOIGNAGES CLIENTS : Mid-South Transplant Foundation, Inc. Validation et mise en routine du C3d
Pour tous les laboratoires d'histocompatibilité, les tests de cytotoxicité dépendante du complément (CDC) s'avèrent longs...
Découvrez notre Laboratoire virtuel
Contactez votre représentant commercial pour une visite personnalisée.
